Verily Forms Strategic Alliances With Novartis, Otsuka, Pfizer And Sanofi To Transform Clinical Research

Verily, an Alphabet company, today announcedstrategic alliances with Novartis , Otsuka, Pfizer Inc. and Sanofi to develop digitally innovative,patient-centered clinical research programs using Project Baseline’s evidence generationplatform and tools. The Baseline Platform is designed to engage more patients and clinicians inresearch, increase the speed and ease of conducting studies and collect more comprehensive, higher quality data, including outside the four walls of a clinic.

Across the United States, the number of people participating in clinical research – including clinical trials and observational studies -- is less than 10% of the population. In addition to low participation, challenges in research include . . .